Stay updated on Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.
Latest updates to the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedSeveral links to clinical trial resources and disease information have been removed, including those related to stomach cancer and specific drug searches, which may impact access to important medical data.SummaryDifference4%
- Check17 days agoChange DetectedNew resources have been added, including links to rare disease information, drug information for Lenvatinib and Pembrolizumab, and various government health websites.SummaryDifference0.4%
- Check24 days agoChange DetectedThe website has been updated to version v2.12.2, adding new features for downloading data in various formats and providing detailed participant and study information, while the previous version v2.12.1 has been removed.SummaryDifference4%
- Check31 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
- Check39 days agoChange DetectedThe website has been updated from version 2.11.2 to 2.12.0, indicating a new release with potential enhancements or features.SummaryDifference0.2%
- Check61 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
Stay in the know with updates to Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galidesivir Safety/PK/Antiviral Effects in Yellow Fever/COVID-19 Clinical Trial page.